Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control
- Conditions
- DiabetesObesity
- Interventions
- Dietary Supplement: Crackers/pasta with added faba bean protein concentrateDietary Supplement: Crackers/pasta with added faba bean flourDietary Supplement: Crackers/pasta with no faba bean fractionDietary Supplement: Crackers/pasta with added faba bean protein isolateDietary Supplement: Crackers/pasta with added faba bean starch
- Registration Number
- NCT02658591
- Lead Sponsor
- University of Toronto
- Brief Summary
The investigators hypothesized that consuming crackers or pasta enriched with faba bean fractions (faba bean protein concentrate, faba bean protein isolate, faba bean flour and faba bean starch), would reduce the blood glucose response to the meal compared to foods without faba bean components and reduce food intake at a meal
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 60
- Non-smoking
- No metabolic disease
- BMI 20 - 25 kg/m^2
- Male
- Age 18-30
- Intolerance to treatments
- Currently taking appetite-modifying medications
- Restrictive eating
- Smoking
- Over- or underweight
- Breakfast-skipping
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Faba bean protein concentrate Crackers/pasta with added faba bean protein concentrate Crackers/pasta with added faba bean protein concentrate Faba bean flour Crackers/pasta with added faba bean flour Crackers/pasta with added faba bean flour Control Crackers/pasta with no faba bean fraction Crackers/pasta with no faba bean fraction Faba bean protein isolate Crackers/pasta with added faba bean protein isolate Crackers/pasta with added faba bean protein isolate Faba bean starch Crackers/pasta with added faba bean starch Crackers/pasta with added faba bean starch
- Primary Outcome Measures
Name Time Method Change in blood glucose levels Starting at the beginning of each session (0 minutes, before consumption of treatment) and every 15 - 30 minutes up to 200 minutes (time of completion of each session) Each participant will attend 5 sessions in total (randomized 5-arm cross-over design)
Change in gut hormone levels measured in the blood Starting at the beginning of each session (0 minutes, before consumption of treatment) and every 30 minutes up to 200 minutes (time of completion of each session) Each participant will attend 5 sessions in total (randomized 5-arm cross-over design)
- Secondary Outcome Measures
Name Time Method Subjective appetite From 0 to 200 minutes Measured using Visual Analog Scales (VAS)
Ad libitum food (pizza meal) intake as measured by the amount of pizza (in grams) consumed during the 20 minute period 120 minutes after completion of treatment, 20 minutes were allocated to allow for pizza consumption Each participant will also answer questions related to physical comfort, motivation to eat, and rating feelings of energy and fatigue using Visual Analog Scales (VAS)
Trial Locations
- Locations (1)
University of Toronto
🇨🇦Toronto, Ontario, Canada